Callan JMB partners with Alabama State University on Atlas Complex biomanufacturing venture
CJMB•Next phase of development
The next phase starts with development of the Marion 9 Biomanufacturing Center at the Atlas Complex.
Revenue-share terms and projections
The agreement grants Callan JMB a 21% participation in gross revenue from pharmaceutical manufacturing operations.
The partnership forecasts annual gross revenue of $500 million, implying about $105 million to Callan JMB in year one.
The company expects more than $400 million in revenue over the five-year agreement based on the revenue-share terms.
Strategic partnership for Atlas Complex
Callan JMB entered a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem at the Atlas Complex in Marion, Alabama.
